	Impact of dose and compliance of antidementia medications on long-term outcomes in Alzheimer's disease: a nationwide real-world study. Alzheimers Res Ther Kim T, Hong YJ, Kim M, Bae Y, Lee SB, Kim SH, Lee MA, Ko E, Park JW, Yang DW. PMID: 41484644 [PubMed - as supplied by publisher]
	Intelectin-1 and systemic inflammation indices as potential biomarkers in alzheimer's disease. Metab Brain Dis Ozkaya AL, Gürbüzer N, Mercantepe F, Klisic A. PMID: 41484390 [PubMed - indexed for MEDLINE]
	A causal deep learning approach to identifying metabolic signatures of cognitive and functional decline in alzheimer's disease. Sci Rep Priyadarshini B, Alex JSR. PMID: 41484308 [PubMed - as supplied by publisher]
	Recent Advances of the Role of Dl-3-n-Butylphthalide in the Treatment of Alzheimer's Disease. Mol Neurobiol Huang H, Wu J, Fang Z, Wang Y, Xie J, Guan Y. PMID: 41484306 [PubMed - indexed for MEDLINE]
	Advances in plasma biomarkers for the diagnosis of Alzheimer's disease. Brain Res Wu H, Liu L, Zeng L. PMID: 41483834 [PubMed - as supplied by publisher]
	Natural glycosides as multi-target neuroprotective agents in Alzheimer's disease: Bridging mechanistic insights and translational potential. Phytomedicine Zhou M, Tang S, Zhang Y, Fu G, Yu W, Wang S, Cheng S, Song Z. PMID: 41483575 [PubMed - as supplied by publisher]
	Spatiotemporal dynamics of tau pathology and neurodegeneration in Medial Temporal Lobe (MTL) subregions across alzheimer's disease progression: A multimodal imaging study using second-generation tracer [(18)F]MK-6240. Eur J Nucl Med Mol Imaging Piao S, Li B, Wang J, He K, Hu B, Yang L, Xie F, Li Y. PMID: 41483305 [PubMed - as supplied by publisher]
	Clinical validation of a voice-based AI tool for screening cognitive impairment: a prospective multicenter study. Neurol Sci Yoon B, Lee HJ, Kim W, Shim YS, Lim EY, Cho AH, Song IW, Hong YJ, Shin HE, Ku BD, Cho SH, Ku H, Shin DH, Yang DW. PMID: 41483033 [PubMed - indexed for MEDLINE]
	Low Intensity Ultrasound-facilitated exosome delivery promotes hippocampal neurogenesis in Alzheimer's disease. Brain Stimul Yan Y, Su J, Xie M, Kong Y, Wang C, Yuan G, Fang Y, Hwang K, Kim CY, Han H, Zhang Z. PMID: 41482153 [PubMed - as supplied by publisher]
	cGAS-STING signaling in Alzheimer's disease: Microglial mechanisms and therapeutic opportunities. Mol Aspects Med Fazal F, Dar NJ, Ahamad S, Khan S, Bano N, Saha S, Nazir A, Bhat SA. PMID: 41481960 [PubMed - as supplied by publisher]
	Dopamine Self-Polymerization-Assisted Oriented Antibody Immobilization on a Transistor for Alzheimer's Disease Diagnosis. Anal Chem Gong X, Li C, Zhou Z, Yu R, Chen Y, Tong J, Liu Y, Qing T, Wu Z, Liu T, Liu X, Liu S. PMID: 41481210 [PubMed - as supplied by publisher]
	Molecular links between inflammatory bowel disease and Alzheimer's disease through immune signaling and inflammatory pathways. World J Gastroenterol Durairajan SSK, Singh AK, Sulaiman SM, Patnaik S, Krishnamoorthi S, Iyaswamy A, Vellingiri B, Yang CB, Williams LL. PMID: 41480321 [PubMed - indexed for MEDLINE]
	Deep multimodal learning for domain-level cognitive decline prediction in Alzheimer's disease. Front Artif Intell García-Gutiérrez F, Matias-Guiu JA, Ayala JL. PMID: 41480285 [PubMed]
	Trends in mortality from Alzheimer's disease and related dementias with hyperlipidemia in the United States from 1999 to 2020-a CDC WONDER database study. Front Neurol Wang J, Xia K, Yang D, Wu J, Liu L, Huang Y, Shan Q, Zhang H, Wang Y. PMID: 41479608 [PubMed]
	A review of evidence supporting amyloid beta reduction as a surrogate endpoint in Alzheimer's disease. J Prev Alzheimers Dis Chen T, Hutchison RM, Rubel C, Murphy J, Xie J, O'Gorman J, Dent G, Molenberghs G, Sormani MP, Hendrix S, Hansson O, Aisen P, Haeberlein SB, Tian Y. PMID: 41478826 [PubMed - as supplied by publisher]
	Multi-omics integration reveals shared genetic architecture between metabolic markers and gray matter atrophy in Alzheimer's Disease. J Prev Alzheimers Dis Wang P, Wu X, Sun F, Zhang H, Jiang Y, Wang Q, Ding H, Zhou Y, Liu F, Liu H. PMID: 41478820 [PubMed - as supplied by publisher]
	Tau in Alzheimer's disease: Shaping the future patient journey. J Prev Alzheimers Dis Mummery CJ, Li-Hsian CC, Lasagna-Reeves CA, Ossenkoppele R, Rowe CC, Scharre DW, Wang H, Kyaga S, Cummings JL. PMID: 41478818 [PubMed - as supplied by publisher]
	Precision therapeutic strategies for Alzheimer's disease: Amyloid Î²-targeted foundations and multimodal next-generation approaches. Mol Cell Neurosci Zafar I, Khan MS, Jamal A, Shafiq S, Bahwerth FS, Khan NU. PMID: 41478541 [PubMed - as supplied by publisher]
	Baseline characteristics of patients with early Alzheimer's disease enrolled in the pivotal trial of low-intensity pulsed ultrasound (LIPUS-AD). J Alzheimers Dis Rep Shimokawa H, Akishita M, Asada T, Katayama S, Hattori Y, Yakushiji Y, Taki Y, Murai H, Boku Y, Tsujimoto M, Umegaki H, Ogawa T, Matsumoto S, Ono K, Imon Y, Tsunemi T, Iwata A, Hanajima R, Hisahara S, Uehara T, Ishiguro T, Nakaoku Y, Ishii K, Ishiki A, Nagai Y, Teramukai S, Ihara M, Fukushima M. PMID: 41477670 [PubMed]
	Higher cerebellum florbetapir uptake in cerebral amyloid angiopathy compared to Alzheimer's disease: A dual florbetapir and FDG PET study. J Alzheimers Dis Rep Sha Y, Jia C, Liang M, Wu J, Zhang T, Zhu Y, Yuan J, Li Q, Huang Z, Cui R, Ni J. PMID: 41477669 [PubMed]

Articles 1 - 20 / 68667

Page 1 of 3434



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy